Development of a Population Pharmacokinetic Model of Vancomycin and its Application in Chinese Geriatric Patients with Pulmonary Infections.

Ying ZhouFeifei GaoChaoyang ChenLingyun MaTing YangXiao LiuYaou LiuXiaoqing WangXia ZhaoChengli QueShuangling LiJiCheng LvYi Min CuiLi Yang

Published in: European journal of drug metabolism and pharmacokinetics (2019)

A population pharmacokinetic model was established to estimate the pharmacokinetics characteristics of Chinese geriatric patients with pulmonary infections, and this model can be used to develop an initial vancomycin dosing regimen for geriatric patients.

Keyphrases

pulmonary hypertension
end stage renal disease
ejection fraction
newly diagnosed
hip fracture
methicillin resistant staphylococcus aureus
prognostic factors
patient reported outcomes